A prospective, multicenter study of once-daily extended-release tacrolimus in de novo liver transplant recipients

Transplantation Proceedings

Volumn 43, Issue 3, 2011, Pages 718-723

  Charco, R ^a   Caralt, M ^a   Llado L ^b   Valdivieso, A ^c   Fabregat, J ^b   Matarranz, A ^c   Gonzalez Pinto, I ^d   Pardo, F ^e   Fabrega E ^f   Bilbao, I ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DE CRUCES   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e UNIVERSITY CLINIC OF NAVARRA   (Spain)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BASILIXIMAB; BILIRUBIN; CREATININE; GLUCOSE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER BIOPSY; LIVER FUNCTION; LIVER GRAFT; LIVER GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPAIN; STATISTICAL SIGNIFICANCE;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; DELAYED-ACTION PREPARATIONS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 79954452218     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.01.093     Document Type: Conference Paper

References (20)

1. P.E. Morrissey, M.L. Flynn, and S. Lin Medication noncompliance and its implications in transplant recipients Drugs 67 2007 1463
2. S. Greenstein, and B. Siegal Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study Transplantation 66 1998 1718
3. L.B. Hilbrands, A.J. Hoitsma, and R.A. Koene Medication compliance after renal transplantation Transplantation 60 1995 914
4. K. Laederach-Hofmann, and B. Bunzel Noncompliance in organ transplant recipients: a literature review Gen Hosp Psychiatry 22 2000 412
5. R.E. O'Carroll, L.M. McGregor, and V. Swanson Adherence to medication after liver transplantation in Scotland: a pilot study Liver Transpl 12 2006 1862
6. G.A. Berlakovich, F. Langer, and E. Freundorfer General compliance after liver transplantation for alcoholic cirrhosis Transpl Int 13 2000 129
7. C.S. Stilley, A.F. DiMartini, and M.E. de Vera Individual and environmental correlates and predictors of early adherence and outcomes after liver transplantation Prog Transplant 20 2010 58 6 quiz 67
8. M. Loghman-Adham Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation Am J Manag Care 9 2003 155
9. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693
10. A. Demetris, K. Batts, and A. Dhillon Banff schema for grading liver allograft rejection: an international consensus document Hepatology 25 1997 658
11. A.S. Levey, J.P. Bosch, and J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461
12. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension J Hypertens 21 2003 1011
13. O. Boillot, D.A. Mayer, and K. Boudjema Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study Liver Transpl 11 2005 61
14. P. Trunecka, O. Boillot, and D. Seehofer Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation Am J Transplant 2010
15. V.C. McAlister, E. Haddad, and E. Renouf Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis Am J Transplant 6 2006 1578
16. C. Moench, F. Ulrich, and W.P. Hofmann Steroid free, tacrolimus once daily based immunosuppression following orthotopic liver transplantation Am J Transplant 10 suppl 4 2010 533
17. S. Florman, R. Alloway, and M. Kalayoglu Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients Transplantation 83 2007 1639
18. M.R. Lucey, M.F. Abdelmalek, and R. Gagliardi A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status Am J Transplant 5 2005 1111
19. M.C. Garber, D.P. Nau, and S.R. Erickson The concordance of self-report with other measures of medication adherence: a summary of the literature Med Care 42 2004 649
20. J. van Hooff, R. Alloway, and P. Trunecka Long-term follow-up experience with tacrolimus once-daily prologned release in kidney, liver and heart transplant recipients Transplantation 90 2010 627 abstr 1188